CYP11B2 and Hypertension resistant to conventional therapy: We identified a novel candidate locus at the DLGAP1 gene with susceptibility to resistant hypertension with genome-wide significant levels, and 18 loci, including CYP11B2 and CACNA1D, as having suggestive association with resistant hypertension in the Japanese population.